These results indicate that the measurement of serum levels of KL-6 and/or MMP-7 could potentially support the diagnosis of IPF and would be useful for identifying vulnerable patients especially when the two markers are used in combination. This evidence concerns the gene MMP7 and idiopathic pulmonary fibrosis.